title: The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells.
abstract: Hypericum perforatum L. (St. John's wort) is a medicinal plant used for many pathologies, especially for the treatment of mild to moderate depression. In the present study we have investigated the cytotoxic activity of the locally collected (Epirus region) Hypericum perforatum L. against cultured T24 and NBT-II bladder cancer cell lines. The lipophilic extract of the herb, prepared using petroleum ether, induced apoptosis displaying LC(50) values at concentrations as low as 4 and 5 microg/mL. A fraction of this extract displayed 60 % cell growth inhibition at a concentration of 0.95 microg/mL. Evaluating the importance of various biologically active components of the extract, it was found that hypericins (hypericin, pseudohypericin, etc.) were identified only in the methanolic (lipophobic) extract of the herb, and not in the active lipophilic extract. In addition, hyperforin concentrations in the lipophilic extract and its most active fraction, were 0.94 microg/mL, and 0.17 microg/mL, respectively, while the active cytotoxic concentration of pure hyperforin appeared in the range of 1.8 microg/mL - 5.0 microg/mL. Therefore, pure hyperforin does not seem to contribute significantly to the cytotoxicity activity. Chlorophylls were identified in low, not significantly different, concentrations in all extracts and fractions and were not correlated to the biological activity. Owing to the combination of significant cytotoxic activity, natural abundance and low toxicity, the lipophilic extract of Hypericum perforatum holds the promise of being an interesting, new, antiproliferative agent against bladder cancer that deserves further investigation.
authors.affiliation: Department of Material Sciences & Engineering, University of Ioannina, Greece. dskalkos@cc.uoi.gr
authors.forename: Dimitris
authors.initials: D
authors.lastname: Skalkos
authors.forename: Nikolaos E
authors.initials: NE
authors.lastname: Stavropoulos
authors.forename: Ioannis
authors.initials: I
authors.lastname: Tsimaris
authors.forename: Eleni
authors.initials: E
authors.lastname: Gioti
authors.forename: Constantine D
authors.initials: CD
authors.lastname: Stalikas
authors.forename: Unyime O
authors.initials: UO
authors.lastname: Nseyo
authors.forename: Elli
authors.initials: E
authors.lastname: Ioachim
authors.forename: Niki J
authors.initials: NJ
authors.lastname: Agnantis
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000737:chemistry / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D045744:Cell Line, Tumor; D006115:Greece; D006801:Humans; D020902:Hypericum / Q000737:chemistry*; D008297:Male; D010840:Phytosterols / Q000737:chemistry / Q000627:therapeutic use; D008517:Phytotherapy; D010936:Plant Extracts / Q000737:chemistry / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D010840:Phytosterols; D010936:Plant Extracts